BioCryst Pharmaceuticals, Inc. (BCRX) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Price: $9.55 -1.14%
Financial Fact:
Loss from operations: -9.24M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: -9.24M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) reported Q2 EPS of ($0.36), $0.11 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $8.04 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
